Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
JanOne has successfully completed the formulation of JAN101, its potential treatment for Peripheral Artery Disease expected to soon be in Phase 2b trials.
read more
MyoKardia and LianBio have entered into a strategic collaboration to develop and commercialize mavacamten in China and other Asian territories.
read more
Bioanalytical Systems, doing business as Inotiv, announced I.M. Grossi, Ph.D., has joined the Company as Vice President, Toxicology.
read more
Trxade announced that its Bonum Health subsidiary has launched a B2B platform which bundles telehealth, a COVID-19 risk assessment tool and a PPE purchasing tool, through a secure mobile dashboard for corporate clients.
read more
The Trendlines Group has expanded its activities to Shanghai with the establishment of Trendlines Medical Shanghai Innovation Center, which has recently started operations.
read more
Thursday, August 13, 2020
Novel and generics pharma producer OncoGenerix and Alpha Capital have come to an agreement to build a new injectable pharmaceutical factory in the US.
read more
Thursday, August 13, 2020
Eyenovia has entered into a license agreement for Arctic Vision to develop and commercialize MicroPine in Greater China and South Korea.
read more
Thursday, August 13, 2020
Ajinomoto Bio-Pharma has announced an expansion of small molecule manufacturing capabilities with the addition of a new production facility in India.
read more
Thursday, August 13, 2020
HTG Molecular Diagnostics announced the signing of a Commercialization and Distribution Agreement with QIAGEN Manchester Limited, a wholly owned subsidiary of QIAGEN.
read more
Wednesday, August 12, 2020
Catalent announced that it has been approved by the FDA to produce commercial drug substance intermediate for AveXis’ spinal muscular atrophy gene therapy.
read more
Wednesday, August 12, 2020
Avacta Group has appointed BBI Solutions to manufacture the saliva-based rapid SARS-CoV-2 antigen test that is being developed with Cytiva.
read more
Wednesday, August 12, 2020
CluePoints announced the success of its complimentary COVID-19 risk management package alongside comprehensive support for COVID-19 affected trials.
read more
Wednesday, August 12, 2020
Caprion-HistoGeneX and Viroclinics-DDL have announced a partnership that will offer global, integrated services to support discovery and development of vaccines and antiviral therapies.
read more
Wednesday, August 12, 2020
NanoImaging Services announced the opening of a new facility close to their San Diego headquarters.
read more
Wednesday, August 12, 2020
The FDA approved the first liquid biopsy companion diagnostic that also uses NGS technology to identify patients with specific types of mutations of the EGFR gene.
read more